LIMITED WAIVER AND FIFTH AMENDMENT TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 3rd, 2023 • Puma Biotechnology, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 3rd, 2023 Company IndustryThis LIMITED WAIVER AND FIFTH AMENDMENT TO NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of July 7, 2023, is entered into by and among PUMA BIOTECHNOLOGY, INC., a Delaware corporation (the “Issuer”), the Guarantors party hereto, the Purchasers party hereto and ATHYRIUM OPPORTUNITIES IV CO-INVEST 1 LP, as the Administrative Agent. All capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in the Note Purchase Agreement (as defined below).